昊帆生物：公司的多肽合成试剂等化学试剂 主要用于酰胺键的化学合成

Group 1 - The core patent of Semaglutide will expire in March next year, which raises questions about its potential positive impact on the company's operations [2] - Haofan Bio (301393.SZ) stated that its main products include peptide synthesis reagents and general molecular building blocks, primarily used for the chemical synthesis of amide bonds [2] - The company's operations are influenced by various factors, including fluctuations in downstream demand, price volatility, industry competition, and capacity layout [2]